Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Harmony Gold Mining ADR | HMY | Nov 15, 2024 | 8.65 | -1.82 |
Harrow | HROW | Nov 15, 2024 | 39.01 | -8.98 |
Hartford Financial Services G Pref | HIG-G | Nov 15, 2024 | 25.13 | -0.08 |
Hartford Financial Services Group | HIG | Nov 15, 2024 | 117.95 | +1.31 |
Hartford Multifactor Developed Markets (ex-US) ETF | RODM | Nov 15, 2024 | 29.17 | +0.03 |
Harvard Bioscience | HBIO | Nov 15, 2024 | 2.14 | -6.55 |
Hasbro | HAS | Nov 15, 2024 | 62.21 | -1.35 |
Haverty Furniture Companies | HVT | Nov 15, 2024 | 22.54 | +0.22 |
Haverty Furniture Companies | HVT-A | Nov 15, 2024 | 22.27 | -0.85 |
Hawaiian Electric Industries | HE | Nov 15, 2024 | 10.28 | +4.47 |
Hawkins | HWKN | Nov 15, 2024 | 123.60 | -0.64 |
Hawthorn Bancshares | HWBK | Nov 15, 2024 | 30.40 | +6.18 |
Haymaker Acquisition 4 | HYAC | Nov 15, 2024 | 10.70 | -0.09 |
Haynes International | HAYN | Nov 15, 2024 | 60.93 | +0.51 |
Hayward | HAYW | Nov 15, 2024 | 16.06 | +1.97 |
HBT Financial | HBT | Nov 15, 2024 | 24.23 | -0.62 |
HCA Healthcare | HCA | Nov 15, 2024 | 342.96 | -0.74 |
HCI Group | HCI | Nov 15, 2024 | 111.98 | -2.55 |
HCM II Acquisition | HOND | Nov 15, 2024 | 10.01 | 0.00 |
HCM II Acquisition | HONDU | Nov 15, 2024 | 10.03 | 0.00 |
HCW Biologics | HCWB | Nov 15, 2024 | 0.29 | -4.66 |
HDFC Bank ADR | HDB | Nov 15, 2024 | 61.90 | -0.02 |
Health Catalyst | HCAT | Nov 15, 2024 | 7.65 | -9.47 |
Healthcare AI Acquisition A | HAIA | Nov 15, 2024 | 11.52 | +0.61 |
Healthcare Alphadex First Trust | FXH | Nov 15, 2024 | 106.75 | -1.99 |
Healthcare Bull 3X Direxion | CURE | Nov 15, 2024 | 101.78 | -5.57 |
Healthcare ETF Vanguard | VHT | Nov 15, 2024 | 260.77 | -2.18 |
Healthcare Realty Trust | HR | Nov 15, 2024 | 17.49 | +0.58 |
Healthcare Select Sector SPDR | XLV | Nov 15, 2024 | 141.84 | -1.85 |
Healthcare Services Group | HCSG | Nov 15, 2024 | 11.54 | -3.27 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.